with all the folks who once again want soap, cars and increasing amounts of pharmaceuticals ……

Group (CRA), Millennium Pharmaceuticals, Human Genome Sciences (HGSI), and deCode Genetics raised ……

and regulatory institutions to work together to monitor the production of pharmaceuticals that use BoNT... markers in their pharmaceuticals. Then scientists could take a survey of the kinds of counterfeit Botox ……

prevents patients from getting cheaper drugs. Another tactic that pharmaceuticals typically use... the way to getting high quality pharmaceuticals for patients.    Take Lilly's recent moves. To survive ……

Pharmaceuticals。    但总的来说，盈利企业在IPO及上市后股价表现方面都优于未盈利企业。平均而言，盈利企业单笔IPO募资规模1.08亿美元，截至发稿前一日收盘，二级市场股价较发行价上涨25.23%。而未... unprofitable, including yesterday's $92 million offering from Sagent Pharmaceuticals (SGNT ……

Pharmaceuticals，该公司本周早些时候筹集了1亿美元。    第一季度唯一遗憾的是没有一场像LinkedIn、Groupon或Zynga这样的重磅IPO。第二季度随着Facebook上市... drug company Merrimack Pharmaceuticals (MACK), which raised $100 million earlier this week.    The only ……

joints. The Pharmaceuticals business sells prescription drugs that include Concerta for attention deficit ……

pharmaceuticals and some biotechs these days is their lack of exposure to the credit markets. Many Big Pharma ……

担任过美国风投协会主席。他指出：“现在通过美国食品及药品管理局审批的时间要比原来长得多，我们甚至还要花更多时间才能弄清楚FDA的想法。Prestwick Pharmaceuticals是我... Partners and former chair of the NVCA. "One of our companies, Prestwick Pharmaceuticals, supposedly ……

of developing new pharmaceuticals for some of the largest companies is approaching $4 to 5 billion ……

.    Drug makers are looking to expand in sectors other than pharmaceuticals, such as generics, vaccines ……

当时似乎让评委不时地惊叹，”TNG Pharmaceuticals的首席执行官詹尼•考宾称，他们是去年的冠军、来自路易斯维尔大学（University of Louisville）的团队。“他们感叹的是产品的粗糙。但我... Pharmaceuticals, last year's winning team from the University of Louisville. "'Aah' over the grossness ……

    向日葵对于我们发展迅速的公司名单而言是个再恰当不过的象徵：它不仅是美国本土的产物（这是公司上榜的前提条件之一）而且它能够达到足以遮蔽其植物界对手的高度. 今年，选择向日葵尤其合适：它的含油量丰富，而这正是大约. 10%. 的最终入围者所生产或交易的产品. ……

）, 巴尔制药（Barr Pharmaceuticals）, 兰伯西（Ranbaxy）和 米兰（Mylan ）-已同意放弃起讼，在2012年之前不挑战塞法隆公司莫达非尼的专利药地位，为此它们获得总共2亿美 ……

本以及美国和欧洲将出台新规章控制生产和专利这一前景也促使学名药制造商纷纷合并。今年1月，以色列学名药巨头Teva Pharmaceuticals斥资4亿美元收购了位于马里兰州的竞争对手CoGenesys公司。据传 ……